522 related articles for article (PubMed ID: 14647429)
41. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression.
Liu ZJ; Xiao M; Balint K; Smalley KS; Brafford P; Qiu R; Pinnix CC; Li X; Herlyn M
Cancer Res; 2006 Apr; 66(8):4182-90. PubMed ID: 16618740
[TBL] [Abstract][Full Text] [Related]
42. Alteration of beta-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients.
Inomata M; Ochiai A; Akimoto S; Kitano S; Hirohashi S
Cancer Res; 1996 May; 56(9):2213-7. PubMed ID: 8616874
[TBL] [Abstract][Full Text] [Related]
43. Tissue-specific expression of beta-catenin in normal mesenchyme and uveal melanomas and its effect on invasiveness.
Kim K; Daniels KJ; Hay ED
Exp Cell Res; 1998 Nov; 245(1):79-90. PubMed ID: 9828103
[TBL] [Abstract][Full Text] [Related]
44. Cadherins, catenins and APC in pleural malignant mesothelioma.
Abutaily AS; Collins JE; Roche WR
J Pathol; 2003 Nov; 201(3):355-62. PubMed ID: 14595746
[TBL] [Abstract][Full Text] [Related]
45. Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin.
Harada N; Miyoshi H; Murai N; Oshima H; Tamai Y; Oshima M; Taketo MM
Cancer Res; 2002 Apr; 62(7):1971-7. PubMed ID: 11929813
[TBL] [Abstract][Full Text] [Related]
46. Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells.
Roh H; Green DW; Boswell CB; Pippin JA; Drebin JA
Cancer Res; 2001 Sep; 61(17):6563-8. PubMed ID: 11522655
[TBL] [Abstract][Full Text] [Related]
47. Oncogenic transformation by beta-catenin: deletion analysis and characterization of selected target genes.
Aoki M; Sobek V; Maslyar DJ; Hecht A; Vogt PK
Oncogene; 2002 Oct; 21(46):6983-91. PubMed ID: 12370820
[TBL] [Abstract][Full Text] [Related]
48. The p38 MAPK pathway is involved in the IL-2 induction of TNF-beta gene via the EBS element.
Xu W; Yan M; Lu L; Sun L; Theze J; Zheng Z; Liu X
Biochem Biophys Res Commun; 2001 Dec; 289(5):979-86. PubMed ID: 11741287
[TBL] [Abstract][Full Text] [Related]
49. Notch1 functions as a tumor suppressor in mouse skin.
Nicolas M; Wolfer A; Raj K; Kummer JA; Mill P; van Noort M; Hui CC; Clevers H; Dotto GP; Radtke F
Nat Genet; 2003 Mar; 33(3):416-21. PubMed ID: 12590261
[TBL] [Abstract][Full Text] [Related]
50. Nuclear export of the APC tumour suppressor controls beta-catenin function in transcription.
Rosin-Arbesfeld R; Cliffe A; Brabletz T; Bienz M
EMBO J; 2003 Mar; 22(5):1101-13. PubMed ID: 12606575
[TBL] [Abstract][Full Text] [Related]
51. The growth-promoting effect of KGF on limbal epithelial cells is mediated by upregulation of DeltaNp63alpha through the p38 pathway.
Cheng CC; Wang DY; Kao MH; Chen JK
J Cell Sci; 2009 Dec; 122(Pt 24):4473-80. PubMed ID: 19920075
[TBL] [Abstract][Full Text] [Related]
52. DeltaNp63alpha repression of the Notch1 gene supports the proliferative capacity of normal human keratinocytes and cervical cancer cells.
Yugawa T; Narisawa-Saito M; Yoshimatsu Y; Haga K; Ohno S; Egawa N; Fujita M; Kiyono T
Cancer Res; 2010 May; 70(10):4034-44. PubMed ID: 20442293
[TBL] [Abstract][Full Text] [Related]
53. Nuclear accumulation of full-length and truncated adenomatous polyposis coli protein in tumor cells depends on proliferation.
Fagman H; Larsson F; Arvidsson Y; Meuller J; Nordling M; Martinsson T; Helmbrecht K; Brabant G; Nilsson M
Oncogene; 2003 Sep; 22(38):6013-22. PubMed ID: 12955080
[TBL] [Abstract][Full Text] [Related]
54. Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells.
Verma UN; Surabhi RM; Schmaltieg A; Becerra C; Gaynor RB
Clin Cancer Res; 2003 Apr; 9(4):1291-300. PubMed ID: 12684397
[TBL] [Abstract][Full Text] [Related]
55. Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids.
Schmelz EM; Roberts PC; Kustin EM; Lemonnier LA; Sullards MC; Dillehay DL; Merrill AH
Cancer Res; 2001 Sep; 61(18):6723-9. PubMed ID: 11559543
[TBL] [Abstract][Full Text] [Related]
56. Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway.
Sharma C; Pradeep A; Wong L; Rana A; Rana B
J Biol Chem; 2004 Aug; 279(34):35583-94. PubMed ID: 15190077
[TBL] [Abstract][Full Text] [Related]
57. P53 mutation as a source of aberrant beta-catenin accumulation in cancer cells.
Cagatay T; Ozturk M
Oncogene; 2002 Nov; 21(52):7971-80. PubMed ID: 12439747
[TBL] [Abstract][Full Text] [Related]
58. Rapid activation of JNK1 in UV-B irradiated epidermal keratinocytes.
Ramaswamy NT; Ronai Z; Pelling JC
Oncogene; 1998 Mar; 16(11):1501-5. PubMed ID: 9525748
[TBL] [Abstract][Full Text] [Related]
59. Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles.
Renard CA; Fourel G; Bralet MP; Degott C; De La Coste A; Perret C; Tiollais P; Buendia MA
Oncogene; 2000 May; 19(22):2678-86. PubMed ID: 10851067
[TBL] [Abstract][Full Text] [Related]
60. Down-regulation of beta-catenin by activated p53.
Sadot E; Geiger B; Oren M; Ben-Ze'ev A
Mol Cell Biol; 2001 Oct; 21(20):6768-81. PubMed ID: 11564862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
